“…In addition, to assess performance for detecting early infection, well-characterized HIV-1 seroconversion panels from the US (presumably subtype B) were obtained from Zeptometrix, Inc. (Buffalo, NY) and BBI-SeraCare Diagnostics [12][13][14]. As previously reported, each panel had at least one specimen that was WB indeterminate (9 seroconverters with 64 total specimens) or WB positive (17 seroconverters with 166 total specimens) and all panels had at least one specimen that was HIV-1 NAT-only positive.…”